Literature DB >> 24298485

Topical Phenytoin Application in Grade I and II Diabetic Foot Ulcers: A Prospective Study.

Vijaya Patil1, Rashmi Patil, P L Kariholu, L S Patil, Praveeen Shahapur.   

Abstract

BACKGROUND: India is fast becoming world diabetes capital. Diabetic foot infections are major problems among innumerable complications associated with diabetes.
MATERIAL AND METHODS: A randomized control study was conducted to evaluate the effect of topical phenytoin on healing in diabetic foot ulcers. One hundred patients with grade I/ II diabetic foot ulcers were randomly divided into two equal groups. Patients subjected to topical phenytoin dressing were classified under study and those who underwent normal salinewound dressings were classified as control. Both the groups were compared in terms of discharge, slough, wound area reduction and duration of hospital stay.
RESULTS: Discharge and slough from wound reduced significantly by day 14 in phenytoin group and within 21 days in control group. Mean duration of hospital stay in phenytoin group was 20 days, whereas in control group, it was 26 days. This difference was statistically significant (p value <0.005,df 1).
CONCLUSION: Hence, Phenytoin proved to be useful as a topical agent in promoting healing and in controlling infections in diabetic foot ulcers.

Entities:  

Keywords:  Diabetic foot ulcers; Topical Phenytoin; Wound healing

Year:  2013        PMID: 24298485      PMCID: PMC3843440          DOI: 10.7860/JCDR/2013/5713.3480

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  22 in total

1.  Clinical and bacteriological survey of diabetic foot infections in Lisbon.

Authors:  J J Mendes; A Marques-Costa; C Vilela; J Neves; N Candeias; P Cavaco-Silva; J Melo-Cristino
Journal:  Diabetes Res Clin Pract       Date:  2011-10-21       Impact factor: 5.602

2.  Role of phenytoin in healing of large abscess cavities.

Authors:  S C Lodha; M L Lohiya; M C Vyas; S Bhandari; R R Goyal; M K Harsh
Journal:  Br J Surg       Date:  1991-01       Impact factor: 6.939

3.  Topical phenytoin treatment of stage II decubitus ulcers in the elderly.

Authors:  R S Rhodes; C A Heyneman; V L Culbertson; S E Wilson; H M Phatak
Journal:  Ann Pharmacother       Date:  2001-06       Impact factor: 3.154

4.  The dysvascular foot: a system for diagnosis and treatment.

Authors:  F W Wagner
Journal:  Foot Ankle       Date:  1981-09

5.  Microbiology at first visit of moderate-to-severe diabetic foot infection with antimicrobial activity and a survey of quinolone monotherapy.

Authors:  Carlo Tascini; Alberto Piaggesi; Enrico Tagliaferri; Elisabetta Iacopi; Serena Fondelli; Anna Tedeschi; Loredana Rizzo; Alessandro Leonildi; Francesco Menichetti
Journal:  Diabetes Res Clin Pract       Date:  2011-08-06       Impact factor: 5.602

6.  The Diabetic Foot.

Authors: 
Journal:  J Am Acad Orthop Surg       Date:  1995-07       Impact factor: 3.020

7.  New insights in diabetic foot infection.

Authors:  Jean-Louis Richard; Albert Sotto; Jean-Philippe Lavigne
Journal:  World J Diabetes       Date:  2011-02-15

8.  Impaired degradation of matrix collagen in human gingival fibroblasts by the antiepileptic drug phenytoin.

Authors:  Takahiro Kato; Nobuo Okahashi; Shinji Kawai; Takafumi Kato; Hiroaki Inaba; Ichijiro Morisaki; Atsuo Amano
Journal:  J Periodontol       Date:  2005-06       Impact factor: 6.993

9.  Preliminary experience with topical phenytoin in wound healing in a war zone.

Authors:  S G el Zayat
Journal:  Mil Med       Date:  1989-04       Impact factor: 1.437

10.  Topical phenytoin in diabetic ulcers: a double blind controlled trial.

Authors:  M R Pai; N Sitaraman; M S Kotian
Journal:  Indian J Med Sci       Date:  2001-11
View more
  7 in total

Review 1.  The application of phenytoin in the treatment of diabetic ulcers.

Authors:  Yi-Shan Liu; Tzong-Shiun Li; Cheuk-Kwan Sun; Kai-Che Wei; Chia-Ju Liu
Journal:  Int Wound J       Date:  2015-10-28       Impact factor: 3.315

2.  Topical phenytoin administration accelerates the healing of acetic acid-induced colitis in rats: evaluation of transforming growth factor-beta, platelet-derived growth factor, and vascular endothelial growth factor.

Authors:  Nima Fattahi; Alina Abdolahi; Zakarya Vahabzadeh; Bahram Nikkhoo; Farhad Manoochehri; Sara Goudarzzadeh; Kambiz Hassanzadeh; Esmael Izadpanah; Mohammad Raman Moloudi
Journal:  Inflammopharmacology       Date:  2022-01-13       Impact factor: 4.473

3.  Phenytoin-loaded bioactive nanoparticles for the treatment of diabetic pressure ulcers: formulation and in vitro/in vivo evaluation.

Authors:  Marwa M Sheir; Maha M A Nasra; Ossama Y Abdallah
Journal:  Drug Deliv Transl Res       Date:  2022-04-11       Impact factor: 4.617

Review 4.  A functional chitosan-based hydrogel as a wound dressing and drug delivery system in the treatment of wound healing.

Authors:  He Liu; Chenyu Wang; Chen Li; Yanguo Qin; Zhonghan Wang; Fan Yang; Zuhao Li; Jincheng Wang
Journal:  RSC Adv       Date:  2018-02-16       Impact factor: 4.036

5.  Re-evaluation of the first phenytoin paste healing effects on oral biopsy ulcers.

Authors:  M Baharvand; A Mortazavi; H Mortazavi; M Yaseri
Journal:  Ann Med Health Sci Res       Date:  2014-11

6.  Novel topical esmolol hydrochloride improves wound healing in diabetes by inhibiting aldose reductase, generation of advanced glycation end products, and facilitating the migration of fibroblasts.

Authors:  Sudhir A Kulkarni; Supreet K Deshpande; Ashu Rastogi
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-23       Impact factor: 6.055

Review 7.  Topical phenytoin for treating pressure ulcers.

Authors:  Xiang Yong Hao; Hong Ling Li; He Su; Hui Cai; Tian Kang Guo; Ruifeng Liu; Lei Jiang; Yan Fei Shen
Journal:  Cochrane Database Syst Rev       Date:  2017-02-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.